NAVB Navidea Biopharmaceuticals
WatchlistNavidea Biopharmaceuticals News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
GainersLongeveron Inc. - Subscription Right (NASDAQ:LGVNR) shares increased by 172.7% to $0.01 during Tuesday's pre-market session. Avinger (NASDAQ:AVGR) shares rose 47.61% to $8.96. The company's mar
12 Health Care Stocks Moving In Thursday's Intraday Session
GainersPhenomeX (NASDAQ:CELL) shares increased by 136.4% to $0.95 during Thursday's regular session. As of 13:31 EST, PhenomeX's stock is trading at a volume of 19.6 million, which is 2758.8% of its a
Navidea Biopharmaceuticals, Inc. NAVB Requests Oral Hearing With NYSE Hearing Panel
Following the Company's Fix, Fund, Propel approach, Navidea formally submitted a request for an oral hearing with New York Stock Exchange American (NYSE American) Hearing Panel to appeal potential delisting of its stock
Why Navidea Biopharmaceuticals Shares Are Nosediving
Navidea Biopharmaceuticals Inc (NASDAQ:NAVB) shares are trading lower by 18.5% to $0.08 after the company announced NYSE American has commenced delisting proceedings and the company intends to appeal.
Navidea Biopharmaceuticals, Inc. Presses Ahead, Embraces Opportunities
Following the Company's Fix, Fund, Propel approach, Navidea continues forward-focus to advance innovative technology to market while intending to appeal the potential delisting of its stock from the N
12 Health Care Stocks Moving In Monday's Pre-Market Session
GainersAllarity Therapeutics (NASDAQ:ALLR) shares increased by 26.6% to $3.33 during Monday's pre-market session. The company's market cap stands at $2.8 million. Better Therapeutics (NASDAQ:BTTX) sha
Navidea Biopharmaceuticals Received Written Notification That NYSE Is Determined To Commence Proceedings To Delist The Company's Stock; The Company's Board Will Appeal The Determination To Commence Delisting Proceedings
Navidea Biopharmaceuticals Received Written Notification That NYSE Is Determined To Commence Proceedings To Delist The Company's Stock; The Company's Board Will Appeal The Determination To Commence De
12 Health Care Stocks Moving In Friday's After-Market Session
GainersIntelligent Bio Solutions (NASDAQ:INBS) stock rose 8.6% to $2.14 during Friday's after-market session. The company's market cap stands at $4.9 million. MSP Recovery (NASDAQ:LIFW) shares increas
NYSE American to Commence Delisting Proceedings Against Navidea Biopharmaceuticals, Inc. (NAVB)
NEW YORK--(BUSINESS WIRE)--NYSE American LLC ("NYSE American" or the "Exchange") announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the common stock of
Express News | Navidea Biopharmaceuticals, Inc. Hires Craig A. Dais, CPA As Chief Financial Officer >NAVB
Express News | Navidea Biopharma Names Dana J Moss to Board; Amit Bhalla Steps Down
Navidea Biopharmaceuticals, Inc. Welcomes Dana J Moss, JD to Board of Directors; Amit Bhalla Steps Down
In line with the Company's Fix, Fund, Propel approach, Dana J Moss, JD joins Navidea's Board, adding depth in legal advice, strategic business, life sciences and technology in support of stated strategy to advance innovative technology to market. Separately, Amit Bhalla steps down from Board.
Express News | Navidea Biopharmaceuticals Rejects Unsolicited Offer From ProPhase Labs to Acquire Certain Assets
ProPhase Labs Says Offer to Acquire Certain Navidea Biopharmaceuticals' Assets Rejected
ProPhase Labs (PRPH) said Thursday it recently made an unsolicited proposal to acquire certain assets of Navidea Biopharmaceuticals (NAVB), which rejected the offer. On June 8, the biotech, genomics a
Navidea Biopharmaceuticals Rejects ProPhase Labs Offer To Acquire Certain Assets of Navidea
Garden City, NY, June 29, 2023 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ:PRPH) ("ProPhase"), a next generation biotech, genomics and diagnostics company, today announced that it recently made an unsolicited offer
12 Health Care Stocks Moving In Thursday's Pre-Market Session
GainersAeglea BioTherapeutics (NASDAQ:AGLE) shares rose 481.2% to $0.62 during Thursday's pre-market session. The company's market cap stands at $40.4 million. Talaris Therapeutics (NASDAQ:TALS) share
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
GainersAdvanced Health (NASDAQ:AHI) stock increased by 143.2% to $1.8 during Wednesday's pre-market session. The market value of their outstanding shares is at $50.4 million. Ocean Biomedical (NASDAQ:
Sector Update: Health Care
Health care stocks were steady late Friday with the NYSE Health Care Index little changed and the Health Care Select Sector SPDR Fund (XLV) up 0.1%. The iShares Biotechnology ETF (IBB) was decreasing
Express News | Prior to Amendment, Navidea Terminated Letter of Intent With Keystone Capital Partners Related to Proposed Sale of Milestone Payment
Express News | Navidea Amends 2016 Agreement With Cardinal